In partnership with

Plus: Illinois' Nov 9 deadline, South Carolina's THCA reversal, and 22 records updated.
§
THE REGULATOR BRIEF
Issue 023 · October 27, 2026
Read on web →
Two engraved clock faces on ink navy, one marked in hot pink: the week's two regulatory clocks
Headlines this week
DEA's judge refuses new testimony — the stay now ends Nov. 5

DEA's chief administrative law judge ruled October 22 on the motions that froze the rescheduling case: the GAO report is in the record, the hearing will not reopen, and the stay expires when briefing closes November 5. No date is set for a recommended decision. Meanwhile the hemp ban's two federal clocks keep running — synthesized cannabinoids November 12, the rest of the redefinition December 11 — and the one legislative off-ramp left is a lame-duck reconciliation long shot. In the states: Illinois manufacturers have until November 9 to file for the new hemp license, New York opens a 50-slot nursery window November 5, and voters in Massachusetts, Idaho and Houston decide cannabis measures November 3.

This week at a glance

Top story. DEA's judge admitted the GAO report but will not reopen the rescheduling hearing; optional briefs close November 5, and the stay lapses then.

Next three.

1.Illinois — the Hemp Act starts November 12; current manufacturers should file for the $5,000 license before November 9.
2.South Carolina — THCA flower was never retail-legal there; our record moved to restricted this week on a re-read of the statute.
3.Ballot — Massachusetts Question 8, Idaho HJR 4 and Houston Proposition A go to voters November 3.
What this means for you this week
•Illinois hemp manufacturers: file for the Hemp Product Manufacturer License before November 9. From November 12, products meant for smoking or vaping cannot be sold as hemp in Illinois at any THC level.
•New Jersey beverage sellers: the November 13 sales cutoff is still the law. S4635 would move it to the federal date, but it has not been enacted.
•Everyone: there is still no adult-use Schedule III date. Calendar November 5, when briefing closes and the stay expires.

Tell us: does the rescheduling timeline change any decision you are making before year-end? Reply to this email. We read every reply, and the answers shape what we cover next.

Advertising opens in this issue — exclusive state, country & category placements from $75/mo. Details below, or skip ahead →
Federal & agency desk
DEA judge admits GAO report, denies motion to reopen rescheduling hearing

Why it matters: The ruling removes the biggest delay risk in the case — a reopened hearing with new witnesses — and gives the stay an end date. It does not set a date for a recommended decision or a final rule, so 280E relief for adult-use operators remains unscheduled. Keep both tax scenarios and talk to your tax adviser.

Chief ALJ Derek C. Julius signed the order October 22 in DEA Docket No. 1362 (Hearing Docket No. 26-96). GAO-26-108623 is admitted as Finn Exhibit 126. Optional briefs, capped at 10 double-spaced pages, are limited to the report's weight and whether its gaps affect the proposal. Briefs are due October 29, replies November 5; parties may not reply to each other's briefs. The government's October 20 opposition called the motion "an obvious fishing expedition."

The hemp ban's two clocks — and which one catches HHC

Why it matters: If HHC falls under the "not capable of being naturally produced" exclusion, it loses federal cover November 12 — two weeks out — not December 11. Anyone holding HHC inventory on a December plan is betting on a classification question with no settled answer.

Section 2019 of P.L. 119-103 (140 Stat. 987) delays the operative date for most of §781 to December 11, 2026, but leaves the exclusion for cannabinoids not capable of being naturally produced by the plant on the original November 12 schedule. HHC occurs in trace amounts naturally; commercial HHC is synthesized at scale. Which prong that puts it under is exactly the kind of line agencies draw in enforcement rather than guidance. We flagged the same issue on our Florida HHC record this week, which previously tied the federal question to December 11 alone; it now carries both dates and the open classification question. The operator work: map every SKU into clearly natural (December 11), clearly synthetic (November 12), and contested — and price the November risk on the third bucket now.

Also on the countdown: eight of FDA's hemp-cannabinoid information-sharing agreements with state regulators — South Carolina, Kentucky, California, Connecticut, Ohio, Oregon, Nevada and Vermont — expire October 31 unless renewed, weeks before the federal limits begin to change. Twelve others run to 2031.

CR-DD4A35D9  Record updated · Florida · HHC · Sale — now carries both federal dates and the open prong question.  View →
Congress's last off-ramp: a hemp bill aimed at reconciliation before Dec. 11

Why it matters: This is the only legislative vehicle left that could replace the December 11 ban with a regulatory framework. If it fails, the split-clock analysis above is the operating reality.

Rep. Morgan Griffith (R-Va.) told Roll Call this week he wants his hemp bill folded into a lame-duck reconciliation package before the deadline. The bill would direct FDA to write rules limiting intoxicating substances in hemp and CBD products within three years, with default caps of 5 mg per serving and 30 mg per package if the agency misses the deadline, possibly paired with the Beverage Regulatory Parity Act's alcohol-style framework for hemp drinks. The constraints are structural: reconciliation provisions need budgetary impact, the Senate has not passed its own budget resolution, Sen. Cynthia Lummis (R-Wyo.) is openly skeptical of syncing the chambers in time, and members including Reps. Andy Harris and Ted Budd want the ban to take effect. Plan for December 11; treat a legislative rescue as upside, not a schedule.

Federal indictment of Virginia Senate leader centers on hemp and CBD storefronts

Why it matters: Federal prosecutors allege marijuana was sold through hemp and CBD shops. The case concerns unlicensed sales — Virginia's adult-use retail market has not opened — and DOJ announced no change in its approach to state-licensed businesses. Hemp retailers selling marijuana-range product remain a federal enforcement target.

DOJ announced October 22 an eight-count indictment in the Eastern District of Virginia against Senate President Pro Tempore L. Louise Lucas and six others. Charges include racketeering conspiracy, distribution of 100 kilograms or more of marijuana, money laundering and honest services fraud. Prosecutors also allege a $750,000 purchase in 2022 of a company holding a co-conspirator's expected adult-use license. An indictment is an allegation; the defendants are presumed innocent.

Statehouse roundup
Illinois — Hemp Act starts November 12, with a new $5,000 manufacturer license

Why it matters: Last week's Illinois story was which products become cannabis. This is the other half: who needs a license to keep selling hemp. The license deadline arrives before the THC line does, and vapes and smokables leave the hemp channel entirely.

The Illinois Department of Agriculture says the Illinois Hemp Act takes effect November 12 and repeals the Industrial Hemp Act. Current manufacturers should apply for the Hemp Product Manufacturer License ($5,000, two years) before November 9. Products that stay in the hemp channel must avoid synthesized cannabinoids, be pre-packaged, lot-tested by an approved Illinois lab with a scannable certificate, carry QR-code labels and use child-resistant packaging. Retailers and distributors need no license.

South Carolina — THCA flower was never retail-legal

Why it matters: A meaningful share of the smokable-hemp market treats South Carolina as an open THCA state. The statute does not support that, and the exposure sits with the retailer, not the brand that shipped the product in.

Our full re-read of the South Carolina hemp framework this week moved our THCA sale record from legal to restricted. The basis is layered: the definitions in S.C. Code § 46-55-10(7) and (9), the operative prohibition in § 46-55-20(A)(1), the 2019 Attorney General opinion, and the Department of Agriculture's position that unlicensed handlers cannot sell raw flower at retail. Read together, THCA flower and pre-rolls at retail do not fit inside the program — whatever the shelf tags in Charleston say.

CR-D4C18AAB  Status change · South Carolina · THCA · Sale — legal → restricted.  View →
Texas — the total-THC test is enforceable again, and THCA was never Schedule I

Why it matters: Products that pass a delta-9-only test can fail a total-THC test. With the Chapter 300 rules back in force, Texas retailers are testing against the stricter standard again — and the widely repeated claim that THCA itself became a Schedule I felony is wrong on both counts.

Two corrections landed on our Texas records this week. First, the procedural posture: a Travis County court blocked the Chapter 300 total-THC rules in April; the Fifteenth Court of Appeals reversed, and the rules are operative. Second, the substance: THCA is not a scheduled substance in Texas. It is restricted through the total-THC calculation, which counts THCA's conversion toward the limit — a regulatory ceiling, not a felony schedule. Our record previously repeated the Schedule I claim; it no longer does, and the revision is logged.

CR-570ECD89  Record updated · Texas · Delta-9 · Sale — Ch. 300 posture corrected; Schedule I claim fixed.  View →
New York — first adult-use nursery licenses, first 50 applications only

Why it matters: New York's market has had no licensed source dedicated to clones and immature plants. A first-come cap means readiness on day one matters more than the strength of the application. Owners cannot hold retail, delivery or consumption interests, so vertically integrated groups face a choice.

OCM opens the nursery application window November 5 and will consider only the first 50 applications; fees for later filings are returned. An information session is set for October 28. The application fee is $1,000. License fees are $750 outdoor, $1,000 mixed-light and $2,000 indoor, with a 50% reduction for social and economic equity applicants.

Hemp beverages — Delaware opens a channel, New Jersey's cutoff holds

Why it matters: Two neighboring states are taking opposite approaches to THC drinks as the federal cap nears. Delaware now regulates them through liquor stores and dispensaries; New Jersey's current law ends hemp-beverage sales November 13 unless the Legislature acts.

Delaware's HB 373 took effect October 21: total THC is capped at 10 mg per container, 60 mg per multipack and 170 mg per 750 mL, sold off-premises by licensed liquor stores, dispensaries or authorized microbreweries; taxes begin February 1, 2027. New Jersey's S4635 would replace the November 13, 2026 date with the federal compliance date — December 11 or later. It has not been enacted. Separately, we rebuilt our New Jersey THCA record this week on the current statute: the framework most summaries still cite, P.L. 2024, c.73 and its $10,000 penalty, was repealed; the operative law is P.L. 2025, c.215 as amended by P.L. 2026, c.7, with definitions effective April 13, 2026.

CR-62D65F58  Record rebuilt · New Jersey · THCA · Sale — re-anchored to P.L. 2025, c.215 / P.L. 2026, c.7.  View →
Enforcement watch — Oklahoma: recalls now flagged in Metrc

Why it matters: Dispensaries will see recall status directly in the tracking system on recalled batches and every downstream package, which shortens the window for selling recalled product unknowingly. HB 4454 labeling and transfer rules begin binding November 1.

OMMA's October 20 recall covers two flower batches from Blue Collar Criminals Collective, LLC that failed yeast and mold testing. OMMA said a visual recall flag now appears in Metrc on recalled batches and downstream packages, effective immediately and for all future recalls. Separately, OMMA's HB 4454 notice bars transfers of non-compliant processor product from November 1.

Across the wires

Developments our desk is tracking that have not yet moved a record — proposed, pending or at the ballot box.

•November 3 ballots — Massachusetts Question 8 would repeal adult-use retail sales effective January 1, 2028; Idaho HJR 4 would reserve legalization to the legislature; Houston Proposition A would deprioritize misdemeanor possession. Records move with the results. MA · ID · Houston
•Massachusetts — the House gave initial approval to a bill letting veterans access medical cannabis without a physician recommendation and adding PTSD, opioid use disorder and chronic pain as qualifying conditions. Pending; no record change until enacted. MM →
•Nebraska — the four licensed medical cultivators petitioned the Medical Cannabis Commission to revise testing, fee and provider-protection rules. Pending; we move the record when the commission does. MM →
International desk
EU Council backs bringing all hemp plant parts under farm-market rules

Why it matters: A single EU framework covering the whole plant would matter for hemp flower and leaf trade, which member states now treat inconsistently. It is a negotiating position, not law; Parliament must agree.

On October 19 the Council of the EU agreed its position on the revised common market organisation regulation, part of the 2028–2034 budget package. The Council kept the Commission's proposal that the hemp sector would cover all hemp plant parts and maintained a 0.3% delta-9 THC threshold. Negotiations with the European Parliament come next.

Greece — CBD possession moves from legal to restricted

Why it matters: EU operators have treated Greece as an open CBD market. Law 5302/2026 changes the baseline, and the national medicines agency reads it as applying immediately — which means the exposure started months ago, not whenever the trade press notices.

Our Greece CBD record moved from legal to restricted this week, dated to the law's May 20, 2026 gazette publication per the EOF's applies-immediately position. Two caveats are logged on the record itself: the entry-into-force article was not read directly, and only the article headings of the operative provision have been verified against the full text. That is what the restricted status rests on today, and the record says so — when the full text is verified, the record updates, not just our confidence.

CR-CC5AC8CA  Status change · Greece · CBD · Possession — legal → restricted, eff. May 20, 2026.  View →
The change log WK 10/20–10/26 · 22 RECORDS UPDATED
Row of engraved document outlines on cream, one filled hot pink: the change-log monitoring motif
The rest of what our monitors caught

Every legality status on cannabisregulations.ai is a versioned record in our own database — built, sourced and refined over two-plus years. Our monitors watch statutes, registers and agency pages directly; when a document changes, a human reviews it before anything publishes. The updates stamped through the stories above came from that pipeline. So did these.

Also updated this week
CR-6CC206B3  West Virginia · Delta-8 · status change — illegal → restricted: W. Va. Code 19-12E-12 names delta-8 as a covered hemp cannabinoid, limited to naturally occurring, non-synthetic product.  →
CR-F941D2D1 +2  Kansas · Delta-8, Delta-9, THCA — AG Opinion 2021-4 reading tightened; format ban re-cited to K.S.A. 2-3908(a); THCA flower bar anchored to 2-3908(b); dead SB 292 tracking removed.  →
CR-99D952A8 +1  Florida · Delta-9, THCA — hemp-extract limit corrected to 0.3% total delta-9 on a wet-weight basis; 2025 amendment reframed as packaging, COA and marketing rules.  →
CR-6B8D4829  Brazil · Possession — ANVISA instruments separated: RDC 1.014/2026 is the sandbox, RDC 1.015/2026 amends RDC 327/2019, cultivation rules effective Aug. 4, 2026.  →
CR-57211FC5  Mexico · Possession — scope of the 2018 jurisprudencia narrowed to what the court actually invalidated.  →
CR-874FAF88 +1  Costa Rica · Colombia — Costa Rica moved medical-only → decriminalized on a re-read of Ley 8204; Colombia's hashish personal-dose figure corrected to 5 g.  →
+7 more  China, Vietnam, Malaysia, Nigeria, Philippines, Sri Lanka, Denmark — effective-date and penalty-detail corrections across the Asia-Pacific and Nordic sweep.  →
Detected · under review

Our monitors flagged these documents as changed. Nothing publishes to our records without human review — until then, here is what we can see.

UNDER REVIEW SIG-00DDFAD3 · 10/26
New Jersey · CRC cannabis-laws page + "Intoxicating Hemp" FAQ (nj.gov)
Our read: both pages were revised the same day, within weeks of the c.215/c.7 framework taking hold. We are checking whether the Commission's guidance changed in substance or only in form before touching the rebuilt record.
UNDER REVIEW SIG-A6492614 · 10/27
Bermuda · Government "Public Awareness Fact Sheet" (gov.bm)
Our read: the page changed twice this week and grew roughly a third in length. We are checking the new content against our current Bermuda possession record.
UNDER REVIEW SIG-10430050 · 10/26
West Virginia · Dept. of Agriculture "Industrial Hemp Licenses" (agriculture.wv.gov)
Our read: the licensing page was revised the same week our Delta-8 record moved. We are checking whether fee or renewal language changed before the record moves again.
UNDER REVIEW SIG-AAF917F7 · 10/24
Missouri · DCR traceability contract documents (health.mo.gov)
Our read: research surfaced a contract-end and re-bid note on the state's Metrc traceability system. The system of record stays Metrc on our pages until the DCR or the procurement portal confirms a change — secondary sourcing does not move a record.
136
Active monitors
1,113
Versioned records
258
Jurisdictions

Every record carries its source, effective date and revision history. Human-reviewed before publishing. Built over two-plus years.

From our database
First complete state legality database
Every cannabinoid. Every state. One database.

Recreational, medical, THCA, Delta-8, Delta-9, HHC, CBD and more — across all 50 states, DC and Puerto Rico, with sources and effective dates on every record. The pages behind every link in this issue.

Open the state laws database →
Partner with us
Subscriber-only · limited slots
Own the page your buyers are already on.

The people reading this — cannabis attorneys, compliance officers, licensed operators across the US, EU, UK and Canada — are the same people searching our state and country legality pages every day: 7,500+ subscribers, 30,000+ monthly site visits. Every placement below is sold as an exclusive: one sponsor per state, one per category. When a slot is booked, it is gone until it lapses.

Presenting sponsor — this newsletter
Top-of-issue billing to 7,500+ regulators, operators & counsel
$450 /issue
Newsletter banner
In-issue placement, one advertiser per send
$325 /issue
State page exclusive
Sole sponsor of a state's legality pages — 50 states, one sponsor each
from $125 /mo
Country page exclusive
158 country pages, strong EU/UK/Canada readership
from $75 /mo
Directory category exclusive
Own your software category — POS, payments, seed-to-sale and more
from $199 /mo
Homepage placement
Site-wide visibility on cannabisregulations.ai
$350 /mo
Request placements →

These rates are currently offered to newsletter subscribers and early users only, ahead of the public media kit.

For attorneys & firms
Your firm may already be listed. Make it yours.

Our lawyer directory lists 575+ cannabis and hemp practices, searchable by state and practice area — the page prospective clients land on when they need counsel in your state. Claiming your listing is free. A paid listing adds:

✓Verified badge on your profile and in search results
✓Featured placement at the top of your state's results
✓Free-consultation flag that filters you into high-intent searches
✓Directory spotlight eligibility in future issues of this brief
Need help with anything in this brief?
Explore our SaaS business directory
Software & services for the industry — POS, payments, seed-to-sale, compliance and more, by category and state.
Browse the business directory →
Find counsel
575+ cannabis & hemp attorneys, by state and practice area.
Lawyer directory →
One thing to read

If you sell hemp in Illinois, read this alongside the license story above: our explainer on the Department of Revenue bulletin sets out which products become cannabis on November 12 and why the state date binds before the federal one. Read the summary →

Find what’s slowing your GTM.

Most GTM problems aren’t one big failure. They’re one or two weak spots quietly dragging down the rest.

The free GTM Audit scores your go-to-market across four dimensions, then sequences a 90-day roadmap for your stage.

Drop your URL. Get your score in about 10 minutes.

Reach the people who write the compliance checks.

The Regulator Brief goes out every Monday to cannabis attorneys, compliance officers, and licensed operators across US states and international jurisdictions. If you want to put your product in front of them, get in touch.

Know someone who'd benefit from this?

Forward it, or use your personal link below. Refer three colleagues and we'll send you our 50-state cannabis legality reference PDF.